The amylin analogue pramlintide suppresses bone resorption without affecting bone formation in individuals with type 1 diabetes and in healthy controls

Mathilde Preskou; David Siersbæk Mathiesen; B. Hartmann; Andreas H. Lange; L K Winther; Jens Juul Holst; Filip Krag Knop; Asger Bach Lund; Jonatan Ising Bagger

doi:10.1007/s00125-025-06497-1

The amylin analogue pramlintide suppresses bone resorption without affecting bone formation in individuals with type 1 diabetes and in healthy controls

Mathilde Preskou, David Siersbæk Mathiesen, B. Hartmann, Andreas H. Lange, L K Winther, Jens Juul Holst, Filip Krag Knop, Asger Bach Lund, Jonatan Ising Bagger

Originalsprog	Engelsk
Artikelnummer	622
Tidsskrift	Diabetologia
Vol/bind	68
Udgave nummer	Suppl 1
Sider (fra-til)	S320
ISSN	0012-186X
DOI	https://doi.org/10.1007/s00125-025-06497-1
Status	Udgivet - okt. 2025
Begivenhed	61th EASD Annual Meeting: EASD 2025 - Wien, Østrig Varighed: 15 sep. 2025 → 19 sep. 2025

Konference

Konference	61th EASD Annual Meeting: EASD 2025
Land/Område	Østrig
By	Wien
Periode	15/09/2025 → 19/09/2025

Adgang til dokumentet

10.1007/s00125-025-06497-1Licens: Ikke-specificeret

Citationsformater

Preskou, M., Mathiesen, D. S., Hartmann, B., Lange, A. H., Winther, L. K., Holst, J. J., Knop, F. K., Lund, A. B., & Bagger, J. I. (2025). The amylin analogue pramlintide suppresses bone resorption without affecting bone formation in individuals with type 1 diabetes and in healthy controls. Diabetologia, 68(Suppl 1), S320. Artikel 622. https://doi.org/10.1007/s00125-025-06497-1

The amylin analogue pramlintide suppresses bone resorption without affecting bone formation in individuals with type 1 diabetes and in healthy controls. / Preskou, Mathilde; Mathiesen, David Siersbæk; Hartmann, B. et al.
I: Diabetologia, Bind 68, Nr. Suppl 1, 622, 10.2025, s. S320.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

@article{e31ed4ab5cbc489ab082689b1a6d0b90,

title = "The amylin analogue pramlintide suppresses bone resorption without affecting bone formation in individuals with type 1 diabetes and in healthy controls",

author = "Mathilde Preskou and Mathiesen, {David Siersb{\ae}k} and B. Hartmann and Lange, {Andreas H.} and Winther, {L K} and Holst, {Jens Juul} and Knop, {Filip Krag} and Lund, {Asger Bach} and Bagger, {Jonatan Ising}",

year = "2025",

month = oct,

doi = "10.1007/s00125-025-06497-1",

language = "English",

volume = "68",

pages = "S320",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "Suppl 1",

note = "61th EASD Annual Meeting: EASD 2025, EASD ; Conference date: 15-09-2025 Through 19-09-2025",

}

TY - ABST

T1 - The amylin analogue pramlintide suppresses bone resorption without affecting bone formation in individuals with type 1 diabetes and in healthy controls

AU - Preskou, Mathilde

AU - Mathiesen, David Siersbæk

AU - Hartmann, B.

AU - Lange, Andreas H.

AU - Winther, L K

AU - Holst, Jens Juul

AU - Knop, Filip Krag

AU - Lund, Asger Bach

AU - Bagger, Jonatan Ising

PY - 2025/10

Y1 - 2025/10

U2 - 10.1007/s00125-025-06497-1

DO - 10.1007/s00125-025-06497-1

M3 - Conference abstract in journal

SN - 0012-186X

VL - 68

SP - S320

JO - Diabetologia

JF - Diabetologia

IS - Suppl 1

M1 - 622

T2 - 61th EASD Annual Meeting: EASD 2025

Y2 - 15 September 2025 through 19 September 2025

ER -